Becton Dickinson (FRA:BOX) 3-Year FCF Growth Rate

: -9.20% (As of Dec. 2023)

View and export this data going back to 1963. Start your Free Trial

Becton Dickinson's Free Cash Flow per Share for the three months ended in Dec. 2023 was €2.28.

During the past 12 months, Becton Dickinson's average Free Cash Flow per Share Growth Rate was 91.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -9.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -3.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Becton Dickinson was 102.80% per year. The lowest was -38.10% per year. And the median was 11.35% per year.

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Becton Dickinson 3-Year FCF Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's 3-Year FCF Growth Rate falls into.

Becton Dickinson 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Becton Dickinson (FRA:BOX) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Becton Dickinson 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Becton Dickinson (FRA:BOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (FRA:BOX) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

BDX:USA BDX:Mexico 1BDX:Italy BOX:Germany BOX:Germany B1DX34:Brazil

Address

1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880

Website

https://www.bd.com

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.